Community-acquired pneumonia in children - a changing spectrum of disease

David M le Roux1,2, Heather J Zar3

  • 15th Floor ICH Building Red Cross War Memorial Children's Hospital, Klipfontein Road Cape Town, 7700, South Africa. Dave.leRoux@uct.ac.za.

Pediatric Radiology
|October 19, 2017
PubMed

Insights

Childhood pneumonia deaths have decreased due to vaccines, but co-infections and viral causes are rising. Improved access to prevention and management strategies is crucial, especially in low-income nations.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Pneumonia is the leading cause of mortality in children globally outside the neonatal period.
  • Significant progress has been made in reducing childhood pneumonia incidence and mortality over the past two decades.

Purpose of the Study:

  • To review the impact of conjugate vaccines on childhood pneumonia.
  • To highlight emerging trends in pneumonia etiology, including co-infections and viral predominance.
  • To identify needs for improved prevention and management strategies.

Main Methods:

  • Review of epidemiological data and vaccine impact studies.
  • Analysis of trends in pneumonia etiology and clinical presentation.
  • Assessment of current prevention and management strategies.

Main Results:

  • Conjugate vaccines against Haemophilus influenzae type b and Streptococcus pneumoniae have significantly reduced pneumonia cases, hospitalizations, and mortality.
  • Emerging evidence points to the increasing importance of co-infections and viral pathogens in childhood pneumonia.
  • Disparities in access to effective interventions persist, particularly in low- and middle-income countries.

Conclusions:

  • Vaccine-preventable bacterial pneumonia has declined, but viral pneumonia and co-infections present ongoing challenges.
  • Enhanced access to existing preventative and management strategies is critical for low- and middle-income countries.
  • Novel strategies are required to address the remaining burden of childhood pneumonia.

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
969
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
949
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
848
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.3K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.6K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
346